Drug intelligence / Profile preview

dendrimer porphyrin micelle

Development stage
Preclinical
Lead developer
The University of Tokyo
Modality
Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Intravenous
01

Overview

Dendrimer porphyrin micelle (DP/M) is an experimental nanomedicine formulation designed for photodynamic therapy (PDT) and photodynamic diagnosis (PDD). It consists of a third-generation aryl ether dendrimer porphyrin with a zinc core encapsulated within a polymeric micelle, typically composed of poly(ethylene glycol)-poly(L-lysine) or poly(aspartic acid) block copolymers. This micellar structure facilitates the selective accumulation of the photosensitizer in tumor tissues and neovascularized areas via the enhanced permeability and retention (EPR) effect. Upon activation by specific wavelengths of light (e.g., 635 nm), the dendrimer porphyrin generates reactive oxygen species (ROS) to induce localized cytotoxicity while minimizing dark toxicity. The formulation also exhibits intense fluorescence, allowing for simultaneous lesion detection and treatment. It has been investigated primarily by researchers at the University of Tokyo for indications such as esophageal cancer, lung carcinoma, and corneal neovascularization.

Other names
micelle-based photosensitizer loading dendrimer porphyrindendrimer porphyrin-loaded micelle

Beyond the preview

Go deeper on dendrimer porphyrin micelle.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on dendrimer porphyrin micelle.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call